Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

OPTIMIZERx Corp OPRX

OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.


NDAQ:OPRX - Post by User

Bullboard Posts
Post by gjervison Jul 14, 2014 10:31am
355 Views
Post# 22742176

Merriman Capital Initiates on OptimizeRx with a Buy

Merriman Capital Initiates on OptimizeRx with a Buyhttps://markets.financialcontent.com/precisionir/news/read?GUID=27686979

SAN FRANCISCO - July 14, 2014 - Merriman Capital, Inc. ("Merriman"), a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), announced that it has initiated equity research coverage of OptimizeRx Corporation (OTCQB: OPRX) with a Buy rating and a $3.00 price target.

OptimizeRx Corporation provides software solutions that offer pharmaceutical manufacturers direct-to-physician channels for communicating and promoting their products. OPRX`s flagship product - SampleMD - allows doctors to access sample vouchers, co-pay coupons, and other patient support through their e-prescribe systems to search, print, or electronically dispense drug samples directly to patients, as well as a network of pharmacies. OptimizeRx was founded in 2007 and is headquartered in Rochester, Michigan.

CLICK HERE FOR FULL REPORT

About Merriman Capital, Inc.

Merriman Capital, Inc. is a full service investment bank and Broker-Dealer that facilitates efficient capital formation through a proprietary digital network, and offers Capital Markets Advisory and comprehensive Corporate Brokerage services for public and private companies. The firm also provides equity and options execution services for sophisticated investors and differentiated research for high growth companies. Merriman Capital, Inc. is a wholly owned brokerage subsidiary of Merriman Holdings, Inc. (OTCQX: MERR) and is a leading advisory firm for publicly traded, high-growth companies.

Digital Capital Network, powered by Merriman Capital, is a capital marketplace that enables highly targeted and more efficient execution of transactions. Please visit our website for more information on how you can be a part of our Digital Capital Network: https://www.digitalcapitalnetwork.com.

Merriman Capital, Inc. is a registered broker-dealer and member of The Financial Industry Regulatory Authority (FINRA) https://www.finra.org/ and the Securities Investor Protection Corporation (SIPC) https://www.sipc.org/.

Bullboard Posts